Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor activity	PDGFRA FLT1 FLT3 FLT4	3.91e-07	7	208	4	GO:0005021
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	5.02e-06	65	208	7	GO:0004714
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	2.99e-05	85	208	7	GO:0019199
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	PDGFRA OBSCN DGKG SNRK PIK3R4 PARP4 POLR1B POLN MERTK FLT1 FLT3 FLT4 CDC42BPA POLR1A ELP1 TEK CDC42BPB SIRT4 CSF1R GYS2 PRKCD PKN1 PRKDC NLK	4.61e-05	938	208	24	GO:0016772
GeneOntologyMolecularFunction	cadherin binding	CTNNAL1 OBSCN EXOC3 PTPRO DIAPH3 RARS1 DBNL APC PKP3 NUMB CTNNA2 ARHGAP18 ZC3HAV1	5.94e-05	339	208	13	GO:0045296
GeneOntologyMolecularFunction	left-handed Z-DNA binding	ADAR ZBP1	1.08e-04	2	208	2	GO:0003692
GeneOntologyMolecularFunction	tRNA-4-demethylwyosine synthase activity	TYW1B TYW1	1.08e-04	2	208	2	GO:0102521
GeneOntologyMolecularFunction	protein tyrosine kinase activity	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R PRKCD	1.42e-04	145	208	8	GO:0004713
GeneOntologyMolecularFunction	protein kinase activity	PDGFRA OBSCN SNRK PIK3R4 MERTK FLT1 FLT3 FLT4 CDC42BPA ELP1 TEK CDC42BPB CSF1R PRKCD PKN1 PRKDC NLK	1.92e-04	600	208	17	GO:0004672
GeneOntologyMolecularFunction	titin binding	OBSCN ACTN2 CAPN3	3.73e-04	14	208	3	GO:0031432
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	PDGFRA OBSCN DGKG SNRK PIK3R4 MERTK FLT1 FLT3 FLT4 CDC42BPA ELP1 TEK CDC42BPB CSF1R PRKCD PKN1 PRKDC NLK	4.68e-04	709	208	18	GO:0016773
GeneOntologyMolecularFunction	histone modifying activity	MIER3 JADE1 KMT2E EHMT2 BRPF1 SIRT4 PKN1 PRKDC KDM1B	6.89e-04	229	208	9	GO:0140993
GeneOntologyBiologicalProcess	pro-B cell differentiation	FLT3 PRKDC SOS1 SOS2	6.19e-06	13	204	4	GO:0002328
GeneOntologyBiologicalProcess	chromatin remodeling	MCM2 OIP5 JADE1 BCL6 KMT2E INO80D EHMT2 SUPT5H BRPF1 SMARCA5 C6orf89 SIRT4 RLF TET1 SMARCA1 SMARCC1 SMARCC2 PKN1 PRKDC KDM1B ZNF304	1.54e-05	741	204	21	GO:0006338
GeneOntologyBiologicalProcess	actin filament-based process	HIP1 STARD8 PDGFRA OBSCN CLASP2 ACTN2 BCL6 RTKN KCNJ2 CACNA1G DIAPH3 FMNL1 CDC42BPA ARHGEF5 CAPN3 DBNL SEMA5A CDC42BPB VANGL2 CSF1R PRKCD CTNNA2 ARHGAP18	3.77e-05	912	204	23	GO:0030029
GeneOntologyBiologicalProcess	actin cytoskeleton organization	HIP1 STARD8 PDGFRA OBSCN CLASP2 ACTN2 BCL6 RTKN DIAPH3 FMNL1 CDC42BPA ARHGEF5 CAPN3 DBNL SEMA5A CDC42BPB VANGL2 CSF1R PRKCD CTNNA2 ARHGAP18	4.99e-05	803	204	21	GO:0030036
MousePheno	increased embryo size	PDGFRA VEZF1 GPC3 SMARCC2	1.20e-06	8	163	4	MP:0001699
Domain	Tyr_kinase_rcpt_3_CS	PDGFRA FLT1 FLT3 FLT4 CSF1R	8.90e-09	8	208	5	IPR001824
Domain	RECEPTOR_TYR_KIN_III	PDGFRA FLT1 FLT3 FLT4 CSF1R	8.90e-09	8	208	5	PS00240
Domain	SANT_dom	MIER3 SMARCA5 SMARCA1 SMARCC1 SMARCC2	8.88e-06	26	208	5	IPR017884
Domain	PROTEIN_KINASE_TYR	PDGFRA OBSCN MERTK FLT1 FLT3 FLT4 TEK CSF1R	1.28e-05	97	208	8	PS00109
Domain	Tyr_kinase_AS	PDGFRA OBSCN MERTK FLT1 FLT3 FLT4 TEK CSF1R	1.28e-05	97	208	8	IPR008266
Domain	SANT	MIER3 SMARCA5 SMARCA1 SMARCC1 SMARCC2	1.30e-05	28	208	5	PS51293
Domain	HEAT	CLASP2 PIK3R4 HEATR4 ECPAS INTS4 PRKDC	1.47e-05	48	208	6	PF02985
Domain	SWIRM	SMARCC1 SMARCC2 KDM1B	2.66e-05	6	208	3	PS50934
Domain	SWIRM	SMARCC1 SMARCC2 KDM1B	2.66e-05	6	208	3	PF04433
Domain	Tyr_kinase_CSF1/PDGF_rcpt	PDGFRA FLT3 CSF1R	2.66e-05	6	208	3	IPR016243
Domain	SWIRM	SMARCC1 SMARCC2 KDM1B	2.66e-05	6	208	3	IPR007526
Domain	Kinase-like_dom	PDGFRA OBSCN SNRK PIK3R4 MERTK FLT1 FLT3 FLT4 CDC42BPA TEK CDC42BPB CSF1R SMARCC1 PRKCD PKN1 PRKDC NLK SOS1	3.82e-05	542	208	18	IPR011009
Domain	HEAT	CLASP2 PIK3R4 HEATR4 ECPAS INTS4 PRKDC	4.44e-05	58	208	6	IPR000357
Domain	Tyr_kinase_cat_dom	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	5.68e-05	88	208	7	IPR020635
Domain	TyrKc	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	5.68e-05	88	208	7	SM00219
Domain	Protein_kinase_ATP_BS	PDGFRA OBSCN SNRK MERTK FLT1 FLT3 FLT4 CDC42BPA TEK CDC42BPB CSF1R PRKCD PKN1 NLK	9.38e-05	379	208	14	IPR017441
Domain	ARM-type_fold	HIP1 CLASP2 PIK3R4 CLTC DIAPH3 FMNL1 HEATR4 APC ECPAS IPO9 PKP3 INTS4 PRKDC	1.15e-04	339	208	13	IPR016024
Domain	Zalpha	ADAR ZBP1	1.23e-04	2	208	2	SM00550
Domain	SLIDE	SMARCA5 SMARCA1	1.23e-04	2	208	2	IPR015195
Domain	ISWI_HAND-dom	SMARCA5 SMARCA1	1.23e-04	2	208	2	IPR015194
Domain	DRADA_REPEAT	ADAR ZBP1	1.23e-04	2	208	2	PS50139
Domain	SMARCC_C	SMARCC1 SMARCC2	1.23e-04	2	208	2	IPR032451
Domain	SMARCC_N	SMARCC1 SMARCC2	1.23e-04	2	208	2	IPR032450
Domain	SWIRM-assoc	SMARCC1 SMARCC2	1.23e-04	2	208	2	IPR032448
Domain	KELK	CDC42BPA CDC42BPB	1.23e-04	2	208	2	IPR031597
Domain	tRNA_wybutosine-synth	TYW1B TYW1	1.23e-04	2	208	2	IPR013917
Domain	dsRNA_A_deaminase	ADAR ZBP1	1.23e-04	2	208	2	IPR000607
Domain	SLIDE	SMARCA5 SMARCA1	1.23e-04	2	208	2	PF09111
Domain	HAND	SMARCA5 SMARCA1	1.23e-04	2	208	2	PF09110
Domain	KELK	CDC42BPA CDC42BPB	1.23e-04	2	208	2	PF15796
Domain	SWIRM-assoc_2	SMARCC1 SMARCC2	1.23e-04	2	208	2	PF16496
Domain	SWIRM-assoc_1	SMARCC1 SMARCC2	1.23e-04	2	208	2	PF16495
Domain	SWIRM-assoc_3	SMARCC1 SMARCC2	1.23e-04	2	208	2	PF16498
Domain	Wyosine_form	TYW1B TYW1	1.23e-04	2	208	2	PF08608
Domain	z-alpha	ADAR ZBP1	1.23e-04	2	208	2	PF02295
Domain	ISWI	SMARCA5 SMARCA1	1.23e-04	2	208	2	IPR029915
Domain	HEAT_REPEAT	CLASP2 PIK3R4 HEATR4 ECPAS INTS4 PRKDC	1.29e-04	70	208	6	PS50077
Domain	PROTEIN_KINASE_ATP	PDGFRA OBSCN SNRK PIK3R4 MERTK FLT1 FLT3 FLT4 CDC42BPA TEK CDC42BPB CSF1R PRKCD PKN1 NLK	2.04e-04	459	208	15	PS00107
Domain	SANT	MIER3 SMARCA5 SMARCA1 SMARCC1 SMARCC2	2.30e-04	50	208	5	SM00717
Domain	SANT/Myb	MIER3 SMARCA5 SMARCA1 SMARCC1 SMARCC2	2.77e-04	52	208	5	IPR001005
Domain	DBINO	SMARCA5 SMARCA1	3.68e-04	3	208	2	IPR020838
Domain	DBINO	SMARCA5 SMARCA1	3.68e-04	3	208	2	PF13892
Domain	CLH	CLTC VPS41	3.68e-04	3	208	2	SM00299
Domain	Prot_kinase_dom	PDGFRA OBSCN SNRK PIK3R4 MERTK FLT1 FLT3 FLT4 CDC42BPA TEK CDC42BPB CSF1R PRKCD PKN1 NLK	3.99e-04	489	208	15	IPR000719
Domain	PROTEIN_KINASE_DOM	PDGFRA OBSCN SNRK PIK3R4 MERTK FLT1 FLT3 FLT4 CDC42BPA TEK CDC42BPB CSF1R PRKCD PKN1 NLK	4.34e-04	493	208	15	PS50011
Domain	Myb_DNA-binding	MIER3 SMARCA5 SMARCC1 SMARCC2	5.97e-04	35	208	4	PF00249
Domain	Pkinase_Tyr	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	6.10e-04	129	208	7	PF07714
Domain	PP2A_PR55_CS	PPP2R2A PPP2R2C	7.30e-04	4	208	2	IPR018067
Domain	Myotonic_dystrophy_kinase_coil	CDC42BPA CDC42BPB	7.30e-04	4	208	2	IPR014930
Domain	Alpha_catenin	CTNNAL1 CTNNA2	7.30e-04	4	208	2	IPR001033
Domain	PP2A_PR55	PPP2R2A PPP2R2C	7.30e-04	4	208	2	IPR000009
Domain	Myotonic_dystrophy_kinase_coil	CDC42BPA CDC42BPB	7.30e-04	4	208	2	PD011252
Domain	PR55_2	PPP2R2A PPP2R2C	7.30e-04	4	208	2	PS01025
Domain	PR55_1	PPP2R2A PPP2R2C	7.30e-04	4	208	2	PS01024
Domain	DMPK_coil	CDC42BPA CDC42BPB	7.30e-04	4	208	2	PF08826
Domain	Pkinase_C	CDC42BPA CDC42BPB PRKCD PKN1	7.40e-04	37	208	4	IPR017892
Domain	-	CLASP2 PIK3R4 HEATR4 APC ECPAS IPO9 PKP3 INTS4 PRKDC	8.82e-04	222	208	9	1.25.10.10
Domain	GDS_CDC24_CS	OBSCN ARHGEF5 SOS1 SOS2	9.06e-04	39	208	4	IPR001331
Domain	Ser-Thr/Tyr_kinase_cat_dom	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	9.09e-04	138	208	7	IPR001245
Domain	Pkinase_C	CDC42BPA CDC42BPB PRKCD PKN1	1.20e-03	42	208	4	PF00433
Domain	Parvalbumin	PPP3R1 PPP3R2	1.21e-03	5	208	2	IPR008080
Domain	Vinculin	CTNNAL1 CTNNA2	1.21e-03	5	208	2	PF01044
Domain	TPR-like_helical_dom	KIFBP TONSL CLTC AIPL1 POLR1A DNAAF4 VPS41 PRKDC LONRF2	1.24e-03	233	208	9	IPR011990
Domain	Clathrin	CLTC VPS41	2.50e-03	7	208	2	PF00637
Domain	RNase_Zc3h12a	ZC3H12B N4BP1	2.50e-03	7	208	2	PF11977
Domain	Hr1	RTKN PKN1	2.50e-03	7	208	2	SM00742
Domain	Vinculin/catenin	CTNNAL1 CTNNA2	2.50e-03	7	208	2	IPR006077
Domain	RNase_Zc3h12_NYN	ZC3H12B N4BP1	2.50e-03	7	208	2	IPR021869
Domain	CHCR	CLTC VPS41	2.50e-03	7	208	2	PS50236
Pathway	KEGG_MEDICUS_REFERENCE_REGULATION_OF_GF_RTK_RAS_ERK_SIGNALING_UBIQUITINATION_OF_RTK_BY_CBL	PDGFRA FLT1 FLT3 FLT4 TEK CSF1R	3.58e-07	25	166	6	M47934
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_PI3K_SIGNALING_PATHWAY	PDGFRA FLT1 FLT3 FLT4 TEK CSF1R SOS1 SOS2	9.81e-06	89	166	8	M47963
Pathway	WP_PI3KAKT_SIGNALING	PDGFRA LAMB4 FLT1 FLT3 FLT4 TEK IFNA4 IFNA16 PPP2R2A PPP2R2C CSF1R GYS2 PKN1 SOS1 SOS2	1.14e-05	339	166	15	M39736
Pathway	KEGG_MEDICUS_REFERENCE_GF_RTK_RAS_ERK_SIGNALING_PATHWAY	PDGFRA FLT1 FLT3 FLT4 TEK CSF1R SOS1 SOS2	1.26e-05	92	166	8	M47927
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	KIFBP HIVEP1 PSMC6 MCM2 GPATCH4 CLASP2 ANKHD1 ADAR PIK3R4 SUPT5H KCTD16 CLTC UQCRC1 RPL36 SMARCA5 POLR1A RARS1 DBNL ELP1 ECPAS PPP2R2A IPO9 PRPF4 SMARCA1 SMARCC1 PRKCD PRKDC AQR RBM34 ZC3HAV1	3.56e-09	1425	212	30	30948266
Pubmed	Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function.	EXOC3 PSMC6 MCM2 GPATCH4 ANKHD1 ADAR PIK3R4 ACSL1 CLTC POLR1B UQCRC1 WDR13 RPL36 SMARCA5 POLR1A RARS1 DBNL ELP1 RLF IPO9 SMARCA1 SMARCC1 SMARCC2 PRKCD PRKDC AQR RBM34 ZC3HAV1	1.80e-08	1353	212	28	29467282
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	OBSCN CLASP2 ATP8B1 PTPN4 TRMT13 UQCRC1 WDR13 MBLAC2 CDC42BPA POLR1A PCDH11Y ENC1 RNF213 GRIK2 VPS54 ECPAS CDC42BPB RLF PPP2R2A PPP2R2C THRB PLXDC2 PKP3 VPS41 NUMB PKN1 NLK ZC3HAV1 SOS2	3.64e-08	1489	212	29	28611215
Pubmed	FBW7 suppresses ovarian cancer development by targeting the N6-methyladenosine binding protein YTHDF2.	EXOC3 MCM2 GPATCH4 ANKHD1 ADAR EHMT2 CLTC RPL36 POLR1A RARS1 ELP1 RNF213 CDC42BPB IPO9 PKP3 SMARCA1 SMARCC2 PRKDC	3.67e-08	601	212	18	33658012
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	HIP1 VEZF1 PSMC6 GPATCH4 CLASP2 ANKHD1 INO80D FBXL6 BLVRB EHMT2 POLR1B UQCRC1 RPL36 CDC42BPA ZNF48 POLR1A RARS1 SFSWAP DBNL APC CDC42BPB HARS2 ZBED6 NUMB CTNNA2 KDM1B MICU2 AQR ZC3HAV1	4.08e-08	1497	212	29	31527615
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	KIFBP MCM2 SNRK JADE1 ANKHD1 STAB1 CACNA1G ZFP82 PLXNB1 CDC42BPA SPG11 ECPAS VANGL2 PPP2R2A CELSR3 TET1	1.89e-07	529	212	16	14621295
Pubmed	Cell cycle-dependent phosphorylation regulates RECQL4 pathway choice and ubiquitination in DNA double-strand break repair.	KIFBP CTNNAL1 EXOC3 PSMC6 MCM2 ANKHD1 ADAR PSMA8 SUPT5H CLTC ACBD3 RPL36 SMARCA5 RARS1 ELP1 SPG11 PPP2R2A IPO9 PRPF4 SMARCA1 SMARCC2 DHX32 PRKDC PCCB RBM34 ZC3HAV1	1.98e-07	1335	212	26	29229926
Pubmed	ZMYM3 regulates BRCA1 localization at damaged chromatin to promote DNA repair.	MIER3 EHMT2 SUPT5H TONSL SMARCA5 RLF SMARCA1 SMARCC1 SMARCC2	3.87e-07	150	212	9	28242625
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	HIVEP1 OBSCN CLASP2 ACTN2 BCL6 KMT2E PARP4 GPC3 EHMT2 CLTC CDC42BPA CAPN3 ELP1 CDC42BPB INTS4	4.75e-07	497	212	15	23414517
Pubmed	A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation.	PSMC6 GPATCH4 ANKHD1 ADAR PARP4 BRPF1 POLR1B DIAPH3 RPL36 POLR1A DBNL APC CDC42BPB PPP2R2A SMARCC1 PCCB GEN1 ZC3HAV1	5.69e-07	724	212	18	36232890
Pubmed	Hypertonicity-responsive ubiquitin ligase RNF183 promotes Na, K-ATPase lysosomal degradation through ubiquitination of its β1 subunit.	HIP1 CTNNAL1 PSMC6 ANKHD1 CLTC DIAPH3 ACBD3 ECPAS VANGL2 IPO9 NUMB N4BP1 PRKDC ZC3HAV1	7.87e-07	449	212	14	31732153
Pubmed	The protein tyrosine kinase family of the human genome.	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	7.94e-07	83	212	7	11114734
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	STAB1 PIK3R4 EHMT2 SUPT5H CLTC UQCRC1 MERTK WDR13 ACBD3 OXR1 ENC1 APC ABCC5 VPS54 CDC42BPB PPP3R1 CELSR3 TMEM168 ZNF451 PRKDC PCCB GEN1 SOS1 SOS2	1.26e-06	1285	212	24	35914814
Pubmed	Analysis of the Histone H3.1 Interactome: A Suitable Chaperone for the Right Event.	MCM2 TONSL SPINDOC RPL36 PPM1B PRPF4 SMARCC1 SMARCC2 PRKDC	1.95e-06	182	212	9	26527279
Pubmed	Characterization of the EGFR interactome reveals associated protein complex networks and intracellular receptor dynamics.	EXOC3 RARS1 ARHGEF5 RNF213 PPP2R2A IPO9 PRKDC SOS1 SOS2	2.04e-06	183	212	9	23956138
Pubmed	EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.	CLASP2 GPC3 CLTC APC PKP3 PRKDC	2.43e-06	63	212	6	29162697
Pubmed	Genetic and Proteomic Interrogation of Lower Confidence Candidate Genes Reveals Signaling Networks in β-Catenin-Active Cancers.	WWC3 OR2T1 PSMC6 GPATCH4 CLASP2 CLTC ACBD3 RNF138 RPL36 SMARCA5 CDC42BPA RARS1 APC PPM1B PPP2R2A IPO9 PRPF4 PKP3 SMARCC1 SMARCC2 PRKDC AQR ZC3HAV1	2.62e-06	1247	212	23	27684187
Pubmed	Using an in situ proximity ligation assay to systematically profile endogenous protein-protein interactions in a pathway network.	HIP1 PDGFRA CLTC FLT1 APC GRM5 PPM1B CSF1R NUMB PRKCD NLK SOS1	3.38e-06	371	212	12	25241761
Pubmed	Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.	MCM2 ADAR SUPT5H CLTC POLR1B SMARCA5 POLR1A APC ELP1 SMARCC1 SMARCC2 AQR ZC3HAV1	3.54e-06	440	212	13	34244565
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	VEZF1 GPATCH4 CLASP2 ANKHD1 PSMA8 FBXL6 BLVRB GPC3 CLTC SMARCA5 CDC42BPA RARS1 SFSWAP ELP1 CDC42BPB HARS2 IPO9 ZNF451 SMARCA1 SMARCC1 SMARCC2 NUMB CTNNA2 RBM34	3.83e-06	1371	212	24	36244648
Pubmed	The chromatin remodelling complex WSTF-SNF2h interacts with nuclear myosin 1 and has a role in RNA polymerase I transcription.	POLR1B SMARCA5 POLR1A	4.41e-06	6	212	3	16514417
Pubmed	Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium.	FLT1 FLT4 TEK	4.41e-06	6	212	3	7596436
Pubmed	Targeting promiscuous heterodimerization overcomes innate resistance to ERBB2 dimerization inhibitors in breast cancer.	PDGFRA MERTK FLT3 FLT4 TEK	4.44e-06	40	212	5	30898150
Pubmed	Systematic bromodomain protein screens identify homologous recombination and R-loop suppression pathways involved in genome integrity.	GPATCH4 ANKHD1 INO80D FBXL6 EHMT2 BRPF1 WDR13 ZFP82 SMARCA5 SFSWAP RNF213 PRR3 VANGL2 EDEM3 PPP2R2A PRPF4 SMARCA1 SMARCC1 SMARCC2 KDM1B SOS1	5.41e-06	1116	212	21	31753913
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	HIVEP1 VEZF1 GPATCH4 EHMT2 BRPF1 ZFP82 SMARCA5 ARHGEF5 RLF ZNF451 SMARCA1 SMARCC1 SMARCC2 KDM1B RBM34	5.62e-06	608	212	15	36089195
Pubmed	ING tumor suppressor proteins are critical regulators of chromatin acetylation required for genome expression and perpetuation.	MCM2 JADE1 BRPF1 SMARCC1 SMARCC2	5.68e-06	42	212	5	16387653
Pubmed	KAP1 facilitates reinstatement of heterochromatin after DNA replication.	KIFBP PSMC6 MCM2 ANKHD1 ADAR EHMT2 CLTC POLR1B UQCRC1 SMARCA5 POLR1A ELP1 PRPF4 SMARCA1 SMARCC1 PRKDC	7.64e-06	704	212	16	29955894
Pubmed	Human transcription factor protein interaction networks.	HIVEP1 VEZF1 PSMC6 GPATCH4 ANKHD1 INO80D EHMT2 UQCRC1 RPL36 SMARCA5 CDC42BPA RARS1 ZNF850 RLF PPP2R2A ZNF451 SMARCA1 SMARCC1 SMARCC2 N4BP1 KDM1B PCCB RBM34 ZC3HAV1	7.66e-06	1429	212	24	35140242
Pubmed	BRIT1/MCPH1 links chromatin remodelling to DNA damage response.	MCM2 SMARCC1 SMARCC2	7.68e-06	7	212	3	19525936
Pubmed	NAC1, a POZ/BTB protein that functions as a corepressor.	ZBTB6 BCL6 ENC1	7.68e-06	7	212	3	19121354
Pubmed	Net-targeted mutant mice develop a vascular phenotype and up-regulate egr-1.	FLT1 FLT4 TEK	7.68e-06	7	212	3	11566878
Pubmed	Target genes of the largest human SWI/SNF complex subunit control cell growth.	SMARCA1 SMARCC1 SMARCC2	7.68e-06	7	212	3	21118156
Pubmed	Mass spectrometry-based proteomic analysis of FSCN1-interacting proteins in laryngeal squamous cell carcinoma cells.	KIFBP ADAR PIK3R4 RPL36 ELP1 PRPF4 PKP3	9.41e-06	120	212	7	31298480
Pubmed	The Hsp70-Hsp90 co-chaperone Hop/Stip1 shifts the proteostatic balance from folding towards degradation.	PSMC6 MCM2 CLASP2 ADAR CLTC ACBD3 SMARCA5 RARS1 ELP1 ECPAS IPO9 PRPF4 SMARCC1 PRKDC ZC3HAV1	9.95e-06	638	212	15	33239621
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	VEZF1 RBM12B ADAR PTPRO SUPT5H CLTC PLXNB1 RPL36 SMARCA5 CDC42BPA SFSWAP APC VANGL2 PRPF4 SMARCC1 INTS4 SMARCC2 PRKDC KDM1B AQR	1.18e-05	1082	212	20	38697112
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	ZBTB6 CTNNAL1 STARD8 OBSCN CLASP2 JADE1 ANKHD1 CLTC ZFP82 PLXNB1 ENC1 DBNL APC TYW1B TET1 SMARCC1 PRKCD TYW1 KDM1B GEN1	1.22e-05	1084	212	20	11544199
Pubmed	Heterozygous Vangl2Looptail mice reveal novel roles for the planar cell polarity pathway in adult lung homeostasis and repair.	PDGFRA FLT1 TEK VANGL2	1.30e-05	24	212	4	28237967
Pubmed	FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia.	OBSCN EXOC3 PSMC6 CLASP2 PIK3R4 GOLGA1 FLT1 SMARCA5 POLR1A SPG11 ECPAS RGS12 RBM34	1.30e-05	497	212	13	36774506
Pubmed	EVI1 oncoprotein interacts with a large and complex network of proteins and integrates signals through protein phosphorylation.	OIP5 EHMT2 PLXNB1 SMARCA5 CDC42BPB SMARCC2 PRKDC	1.43e-05	128	212	7	23858473
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	EFCAB5 ADAR BRPF1 CLTC SMARCA5 CDC42BPA SMARCC1 SMARCC2 ZC3HAV1	1.49e-05	234	212	9	36243803
Pubmed	Systematically defining selective autophagy receptor-specific cargo using autophagosome content profiling.	PSMC6 MCM2 GPATCH4 ANKHD1 STK11IP ADAR CLTC UQCRC1 DIAPH3 RARS1 DBNL APC CDC42BPB EDEM3 PKP3 SMARCC2 NUMB PRKDC CTNNA2 AQR RBM34 ZC3HAV1	1.61e-05	1297	212	22	33545068
Pubmed	Involvement of insulin-like growth factor 2 in angiogenic factor transcription in Bi-maternal mouse conceptuses.	FLT1 FLT4 TEK	1.83e-05	9	212	3	19881219
Pubmed	Expression of planar cell polarity genes during development of the mouse CNS.	VANGL2 CELSR3 PRICKLE2	1.83e-05	9	212	3	16487141
Pubmed	Combinatorial targeting of a chromatin complex comprising Dot1L, menin and the tyrosine kinase BAZ1B reveals a new therapeutic vulnerability of endocrine therapy-resistant breast cancer.	MCM2 GPATCH4 ADAR EHMT2 BRPF1 POLR1B RPL36 SMARCA5 CDC42BPA POLR1A SFSWAP PRPF4 SMARCC2 PRKDC AQR RBM34 ZC3HAV1	1.96e-05	847	212	17	35850772
Pubmed	Systematic mapping of genetic interactions for de novo fatty acid synthesis identifies C12orf49 as a regulator of lipid metabolism.	PDGFRA VEZF1 PSMC6 GPATCH4 CLASP2 JADE1 INO80D ACSL1 EHMT2 CLTC DIAPH3 RPL36 SPG11 GRIK2 VPS54 RLF IPO9 THRB VPS41 SMARCC1 RBM34 SOS1	2.28e-05	1327	212	22	32694731
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	HIVEP1 MCM2 BRPF1 CLTC SMARCA5 SFSWAP SEMA5A ECPAS PKP3 SMARCC1 SMARCC2 PRKCD PKN1 PRKDC ZC3HAV1 SOS1	2.43e-05	774	212	16	15302935
Pubmed	Novel splice variants derived from the receptor tyrosine kinase superfamily are potential therapeutics for rheumatoid arthritis.	FLT1 FLT4 TEK CSF1R	2.45e-05	28	212	4	18593464
Pubmed	The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF.	FLT1 FLT4 TEK	2.60e-05	10	212	3	10395786
Pubmed	Probing chromatin landscape reveals roles of endocardial TBX20 in septation.	PDGFRA ACTN2 TEK	2.60e-05	10	212	3	27348591
Pubmed	Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice.	FLT1 FLT4 TEK	2.60e-05	10	212	3	7596435
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	CTNNAL1 EXOC3 PSMC6 CLASP2 PTPN4 SUPT5H CLTC RPL36 CDC42BPA ELP1 RNF213 CDC42BPB PPM1B PPP2R2A IPO9 PPP3R1 PRPF4 INTS4 NUMB	2.60e-05	1049	212	19	27880917
Pubmed	Dosage-dependent requirement for mouse Vezf1 in vascular system development.	VEZF1 FLT1 FLT4 TEK	2.83e-05	29	212	4	15882861
Pubmed	A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB.	PXYLP1 CAPN5 FLT1 VANGL2 VPS41	2.83e-05	58	212	5	19734545
Pubmed	An atlas of combinatorial transcriptional regulation in mouse and man.	ZBTB6 MCM2 JADE1 BCL6 ZNF235 EHMT2 SUPT5H BRPF1 TONSL POLR1B ZFP82 SMARCA5 POLR1A APC THRB ZNF451 SMARCA1	3.04e-05	877	212	17	20211142
Pubmed	Purification and identification of protein-tyrosine kinase-binding proteins using synthetic phosphopeptides as affinity reagents.	CLTC CSF1R SOS1	3.55e-05	11	212	3	15215307
Pubmed	Reduced mTORC1-signaling in retinal ganglion cells leads to vascular retinopathy.	PDGFRA FLT1 FLT4	3.55e-05	11	212	3	34148274
Pubmed	Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15.	RBM12B PSMC6 MCM2 ANKHD1 ADAR PSMA8 CLTC UQCRC1 ALDH6A1 RPL36 SMARCA5 PPP2R2A PRPF4 PRKDC AQR	3.65e-05	714	212	15	28302793
Pubmed	Aberrant deltaPKC activation in the spinal cord of Wobbler mouse: a model of motor neuron disease.	VPS54 PRKCD	3.70e-05	2	212	2	15649703
Pubmed	The Swi3 protein plays a unique role in regulating respiration in eukaryotes.	SMARCC1 SMARCC2	3.70e-05	2	212	2	27190130
Pubmed	Evidence for opposing roles of Celsr3 and Vangl2 in glutamatergic synapse formation.	VANGL2 CELSR3	3.70e-05	2	212	2	28057866
Pubmed	ADAR1 and ZBP1 in innate immunity, cell death, and disease.	ADAR ZBP1	3.70e-05	2	212	2	36710220
Pubmed	Characterization of the interaction of phorbol esters with the C1 domain of MRCK (myotonic dystrophy kinase-related Cdc42 binding kinase) alpha/beta.	CDC42BPA CDC42BPB	3.70e-05	2	212	2	18263588
Pubmed	Csf1r or Mer inhibition delays liver regeneration via suppression of Kupffer cells.	MERTK CSF1R	3.70e-05	2	212	2	31042769
Pubmed	Critical Requirement of SOS1 for Development of BCR/ABL-Driven Chronic Myelogenous Leukemia.	SOS1 SOS2	3.70e-05	2	212	2	36010887
Pubmed	Inactivation of DNA-dependent protein kinase by protein kinase Cdelta: implications for apoptosis.	PRKCD PRKDC	3.70e-05	2	212	2	9774685
Pubmed	Different roles of Numb-p72 and Numb-p65 on the trafficking of metabotropic glutamate receptor 5.	GRM5 NUMB	3.70e-05	2	212	2	33394235
Pubmed	Frequency and histological appearance of adenomas in multiple intestinal neoplasia mice are unaffected by severe combined immunodeficiency (scid) mutation.	APC PRKDC	3.70e-05	2	212	2	8567125
Pubmed	Crystal structure of the Zalpha domain of the human editing enzyme ADAR1 bound to left-handed Z-DNA.	ADAR ZBP1	3.70e-05	2	212	2	10364558
Pubmed	Discovery of a gene family critical to wyosine base formation in a subset of phenylalanine-specific transfer RNAs.	TYW1B TYW1	3.70e-05	2	212	2	16162496
Pubmed	SOS2 Comes to the Fore: Differential Functionalities in Physiology and Pathology.	SOS1 SOS2	3.70e-05	2	212	2	34205562
Pubmed	Spindle Assembly Disruption and Cancer Cell Apoptosis with a CLTC-Binding Compound.	CLTC APC	3.70e-05	2	212	2	29769406
Pubmed	SIRT4 loss reprograms intestinal nucleotide metabolism to support proliferation following perturbation of homeostasis.	APC SIRT4	3.70e-05	2	212	2	38507411
Pubmed	Molecular cloning of murine FLT and FLT4.	FLT1 FLT4	3.70e-05	2	212	2	8393164
Pubmed	Cloning and chromosomal localization of human Cdc42-binding protein kinase beta.	CDC42BPA CDC42BPB	3.70e-05	2	212	2	10198171
Pubmed	A homologue of the Drosophila Son of sevenless gene maps to mouse chromosome 17.	SOS1 SOS2	3.70e-05	2	212	2	8307589
Pubmed	Differential Expression of VEGFA Isoforms Regulates Metastasis and Response to Anti-VEGFA Therapy in Sarcoma.	FLT1 PRKDC	3.70e-05	2	212	2	28377452
Pubmed	Molecular cloning and characterization of the cDNA encoding the largest subunit of mouse RNA polymerase I.	POLR1B POLR1A	3.70e-05	2	212	2	9236775
Pubmed	Structure of the DLM-1-Z-DNA complex reveals a conserved family of Z-DNA-binding proteins.	ADAR ZBP1	3.70e-05	2	212	2	11524677
Pubmed	Efficacy of a Mer and Flt3 tyrosine kinase small molecule inhibitor, UNC1666, in acute myeloid leukemia.	MERTK FLT3	3.70e-05	2	212	2	25762638
Pubmed	Specific targeting of PKCδ suppresses osteoclast differentiation by accelerating proteolysis of membrane-bound macrophage colony-stimulating factor receptor.	CSF1R PRKCD	3.70e-05	2	212	2	31065073
Pubmed	The mammalian Golgi regulates numb signaling in asymmetric cell division by releasing ACBD3 during mitosis.	ACBD3 NUMB	3.70e-05	2	212	2	17418793
Pubmed	Vangl2 interaction plays a role in the proteasomal degradation of Prickle2.	VANGL2 PRICKLE2	3.70e-05	2	212	2	30814664
Pubmed	Cryo-EM structures of human RNA polymerase I.	POLR1B POLR1A	3.70e-05	2	212	2	34887565
Pubmed	Stem-like progenitor and terminally differentiated TFH-like CD4+ T cell exhaustion in the tumor microenvironment.	BCL6 PRKDC	3.70e-05	2	212	2	38363680
Pubmed	The biochemical activation of T-type Ca2+ channels in HEK293 cells stably expressing alpha1G and Kir2.1 subunits.	KCNJ2 CACNA1G	3.70e-05	2	212	2	15465033
Pubmed	Dendritic cells induce Th2-mediated airway inflammatory responses to house dust mite via DNA-dependent protein kinase.	PRKCD PRKDC	3.70e-05	2	212	2	25692509
Pubmed	Two Distantly Spaced Basic Patches in the Flexible Domain of Huntingtin-Interacting Protein 1 (HIP1) Are Essential for the Binding of Clathrin Light Chain.	HIP1 CLTC	3.70e-05	2	212	2	22820750
Pubmed	Macrophage colony-stimulating factor receptor marks and regulates a fetal myeloid-primed B-cell progenitor in mice.	FLT3 CSF1R	3.70e-05	2	212	2	27207794
Pubmed	Absence of both Sos-1 and Sos-2 in peripheral CD4(+) T cells leads to PI3K pathway activation and defects in migration.	SOS1 SOS2	3.70e-05	2	212	2	25973715
Pubmed	ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis.	ADAR ZBP1	3.70e-05	2	212	2	35614224
Pubmed	sVEGF R1 and Tie-2 levels during chemotherapy of lung cancer patients.	FLT1 TEK	3.70e-05	2	212	2	22836649
Pubmed	Identification of murine homologues of the Drosophila son of sevenless gene: potential activators of ras.	SOS1 SOS2	3.70e-05	2	212	2	1631150
Pubmed	ADAR1 protein induces adenosine-targeted DNA mutations in senescent Bcl6 gene-deficient cells.	BCL6 ADAR	3.70e-05	2	212	2	23209284
Pubmed	The Ras-specific exchange factors mouse Sos1 (mSos1) and mSos2 are regulated differently: mSos2 contains ubiquitination signals absent in mSos1.	SOS1 SOS2	3.70e-05	2	212	2	9372945
Pubmed	Chromosomal localization of FLT4, a novel receptor-type tyrosine kinase gene.	FLT3 FLT4	3.70e-05	2	212	2	1319394
Pubmed	Chromosomal localization of two genes encoding human ras exchange factors: SOS1 maps to the 2p22-->p16 region and SOS2 to the 14q21-->q22 region of the human genome.	SOS1 SOS2	3.70e-05	2	212	2	8275713
Pubmed	BCL6 modulates tonic BCR signaling in diffuse large B-cell lymphomas by repressing the SYK phosphatase, PTPROt.	BCL6 PTPRO	3.70e-05	2	212	2	19855081
Pubmed	Transferrin Receptor Protein 1 Cooperates with mGluR2 To Mediate the Internalization of Rabies Virus and SARS-CoV-2.	ADAR CLTC RPL36 SMARCA5 RARS1 IPO9 SMARCC1 SMARCC2 PRKDC ZC3HAV1	4.19e-05	333	212	10	36779763
Pubmed	A multi-factor trafficking site on the spliceosome remodeling enzyme BRR2 recruits C9ORF78 to regulate alternative splicing.	EXOC3 ADAR ACSL1 SUPT5H CLTC UQCRC1 SMARCA5 ELP1 ECPAS IPO9 SMARCC1 INTS4 AQR	4.47e-05	560	212	13	35241646
Pubmed	The ubiquitin-specific protease USP36 SUMOylates EXOSC10 and promotes the nucleolar RNA exosome function in rRNA processing.	GPATCH4 ADAR CLTC POLR1B RPL36 SMARCA5 POLR1A RARS1 PRPF4 PRKDC RBM34 ZC3HAV1	4.61e-05	483	212	12	36912080
Interaction	LYN interactions	CTNNAL1 EXOC3 RNF138 FLT3 CDC42BPA ZNF577 POLR1A ARHGEF5 APC ABCC5 CDC42BPB VANGL2 CSF1R PRPF4 SMARCA1 NUMB PRKCD TYW1 PRKDC RBM34 ZC3HAV1	1.42e-05	720	204	21	int:LYN
Interaction	CRKL interactions	PDGFRA PSMC6 MCM2 GPATCH4 PTPN4 FLT1 ARHGEF5 PRR3 TMEM168 SOS1 SOS2	2.10e-05	227	204	11	int:CRKL
Interaction	SIRT6 interactions	PSMC6 MCM2 ADAR EHMT2 SUPT5H TONSL CLTC POLR1B SMARCA5 POLR1A HUS1 APC ELP1 CELSR3 SMARCC1 SMARCC2 PRKDC AQR ZC3HAV1	2.25e-05	628	204	19	int:SIRT6
Interaction	CENPA interactions	KIFBP HIVEP1 OIP5 GPATCH4 BRPF1 DIAPH3 SMARCA5 ECPAS RLF ZNF451 SMARCA1 SMARCC1 PRKDC RBM34	3.20e-05	377	204	14	int:CENPA
Interaction	SERTAD4 interactions	ZNF235 CBLL2 PPP2R2A PPP2R2C	3.51e-05	19	204	4	int:SERTAD4
Interaction	KLF9 interactions	HIVEP1 GPATCH4 ANKHD1 EHMT2 RLF SMARCA1 RBM34	4.46e-05	93	204	7	int:KLF9
Interaction	BAZ1B interactions	SUPT5H MERTK FLT1 FLT3 SMARCA5 TEK SMARCA1 SMARCC1 SMARCC2 ZC3HAV1	4.54e-05	204	204	10	int:BAZ1B
Interaction	H3C3 interactions	HIVEP1 VEZF1 MCM2 GPATCH4 EHMT2 BRPF1 TONSL ZFP82 SMARCA5 RLF SMARCA1 SMARCC1 SMARCC2 KDM1B FBLIM1 RBM34	4.69e-05	495	204	16	int:H3C3
Interaction	ATG16L1 interactions	KIFBP HIP1 WWC3 EXOC3 OIP5 CLASP2 STK11IP CLTC DIAPH3 FMNL1 RPL36 SMARCA5 POLR1A RARS1 SFSWAP DBNL APC ELP1 VPS54 NLRP6 PPP2R2A IPO9 SMARCC1 SMARCC2 DHX32 PCCB ZC3HAV1	4.72e-05	1161	204	27	int:ATG16L1
Interaction	YTHDC2 interactions	FBXL6 FLT1 RPL36 FLT3 FLT4 ZNF48 TEK PRR3 ARHGAP18 ZC3HAV1	4.73e-05	205	204	10	int:YTHDC2
Interaction	NCF4 interactions	EXOC3 CAPN5 PRKCD PRKDC	6.46e-05	22	204	4	int:NCF4
Interaction	SSRP1 interactions	MCM2 JADE1 ADAR SUPT5H BRPF1 TONSL MERTK FMNL1 SMARCA5 POLR1A TEK PPM1B RLF PRPF4 SMARCA1 SMARCC1 INTS4 PRKDC AQR	7.24e-05	685	204	19	int:SSRP1
Cytoband	Ensembl 112 genes in cytogenetic band chr9q31	CTNNAL1 OR13C5 OR13C9 OR13C2 ELP1 ECPAS PPP3R2	3.87e-06	137	213	7	chr9q31
Cytoband	9q31.1	OR13C5 OR13C9 OR13C2 PPP3R2	3.99e-05	41	213	4	9q31.1
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	PDGFRA MERTK FLT1 FLT3 FLT4 TEK CSF1R	4.99e-08	40	158	7	321
GeneFamily	Protein phosphatase 3 regulatory subunits\|EF-hand domain containing	PPP3R1 PPP3R2	7.59e-05	2	158	2	697
GeneFamily	GATA zinc finger domain containing\|Myb/SANT domain containing	MIER3 SMARCA5 SMARCA1 SMARCC1 SMARCC2	9.79e-05	53	158	5	532
GeneFamily	Olfactory receptors, family 13	OR13C5 OR13C9 OR13C2	1.02e-03	23	158	3	162
GeneFamily	Zinc fingers C2H2-type\|ZF class homeoboxes and pseudogenes	ZBTB6 HIVEP1 ZNF562 VEZF1 BCL6 ZNF235 ZFP82 ZNF48 ZNF577 ZNF484 ZNF670 ZNF850 RLF ZNF451 ZNF304	1.59e-03	718	158	15	28
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	OBSCN ARHGEF5 SOS1 SOS2	2.66e-03	66	158	4	722
GeneFamily	EF-hand domain containing	EFCAB5 DGKG EFHC1 CAPN3 PPP3R1 PPP3R2 MICU2	3.17e-03	219	158	7	863
GeneFamily	C2 domain containing protein kinases	PRKCD PKN1	3.26e-03	10	158	2	835
GeneFamily	Zinc fingers CCCH-type	ZC3H12B PRR3 ZC3HAV1	3.49e-03	35	158	3	73
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP1 VEZF1 CLASP2 ATP8B1 MBOAT2 PIK3R4 PTPN4 ACBD3 SMARCA5 CDC42BPA ENC1 APC SEMA5A SPG11 PRR3 PPM1B RLF PPP2R2A PPP3R1 ZNF451 SMARCA1 NUMB N4BP1 MICU2 AQR SOS1 SOS2	1.40e-09	856	210	27	M4500
Coexpression	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN	PDGFRA FLT1 FLT4 TEK CSF1R	5.31e-06	32	210	5	MM17
Coexpression	CUI_TCF21_TARGETS_2_DN	HIP1 HIVEP1 STARD8 SNRK ATP8B1 JADE1 INO80D PARP4 PTPRO MERTK FLT1 MBLAC2 SEMA5A VPS54 ECPAS TEK EDEM3 PLXDC2 NLK ZC3HAV1 SOS2	5.71e-06	854	210	21	M1533
Coexpression	LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_KINASES_DN	PDGFRA FLT1 FLT4 TEK CSF1R	7.25e-06	34	210	5	M45005
Coexpression	CUI_TCF21_TARGETS_2_DN	HIP1 HIVEP1 STARD8 SNRK ATP8B1 JADE1 INO80D PARP4 PTPRO MERTK FLT1 MBLAC2 SEMA5A VPS54 ECPAS TEK EDEM3 PLXDC2 NLK ZC3HAV1 SOS2	1.03e-05	888	210	21	MM1018
Coexpression	IBRAHIM_NRF2_UP	MIER3 DGKG ACSL1 MERTK ACBD3 ENOX2 RARS1 VPS54 PPM1B EDEM3 PPP3R1 TMEM168 VPS41 NUMB MICU2	2.86e-05	533	210	15	M42510
Coexpression	GSE13493_DP_VS_CD8POS_THYMOCYTE_DN	ACTN2 ADAR TONSL POLR1B RARS1 ENC1 PRKDC ARHGAP18 AQR	3.60e-05	200	210	9	M3315
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	VEZF1 MIER3 STK11IP PIK3R4 EFHC1 CDC42BPA CDC42BPB CSF1R NLK	1.94e-07	177	213	9	946803293a7955116c80f403e99e4093e798ca3f
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HIP1 PDGFRA DGKG XYLT1 CACNA1G SEMA5A GRIK2 TEK GRM5	3.53e-07	190	213	9	6c7e1086c0a274cd5527c3104106e372811c9905
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|(1)_Control_(PBS) / Stress and Cell class	CTNNAL1 SNRK ATP8B1 STAB1 CLTC FLT1 FLT4 TEK FBLIM1	3.86e-07	192	213	9	e16e49b302019474232ef4cc0ff217d33afe34cf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	SIRPB2 STAB1 ACSL1 MERTK FMNL1 FLT3 CSF1R PLXDC2 ARHGAP18	4.79e-07	197	213	9	8af4a1e35ce9fb4ea3d26ab619599efb7eac43a5
ToppCell	Macroglial-Polydendrocytes\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PDGFRA XYLT1 PTPRO KCTD16 PCDH11Y SEMA5A GRIK2 TEK GRM5	5.43e-07	200	213	9	961858738ce35db8760c8c2e136f8369bc444ccf
ToppCell	Macroglial-Polydendrocytes-PDGFRA-\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PDGFRA XYLT1 PTPRO KCTD16 PCDH11Y SEMA5A GRIK2 TEK GRM5	5.43e-07	200	213	9	f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2
ToppCell	Macroglial-Polydendrocytes-PDGFRA--\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PDGFRA XYLT1 PTPRO KCTD16 PCDH11Y SEMA5A GRIK2 TEK GRM5	5.43e-07	200	213	9	cc3409518f8b436ea92deb955e81114b3f410ff7
ToppCell	Macroglial-Polydendrocytes-PDGFRA\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PDGFRA XYLT1 PTPRO KCTD16 PCDH11Y SEMA5A GRIK2 TEK GRM5	5.43e-07	200	213	9	c24a3099e3d96d8b72f6d05286bb355d661a0377
ToppCell	Macroglial-Polydendrocytes-PDGFRA---\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PDGFRA XYLT1 PTPRO KCTD16 PCDH11Y SEMA5A GRIK2 TEK GRM5	5.43e-07	200	213	9	4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca
ToppCell	Macroglial-Polydendrocytes-PDGFRA----L1-6\|Macroglial / cells hierarchy compared to all cells using T-Statistic	PDGFRA XYLT1 PTPRO KCTD16 PCDH11Y SEMA5A GRIK2 TEK GRM5	5.43e-07	200	213	9	310cd53db1c137f6af74e6ae682221d7ac27310c
ToppCell	Control-Myeloid-Dendritic_cells\|Control / group, cell type (main and fine annotations)	SIRPB2 STAB1 XYLT1 ACSL1 FLT3 CSF1R PLXDC2 ARHGAP18	2.57e-06	180	213	8	25ad95c3c30e3b82abe93bd77ba003f5c2241f7c
ToppCell	renal_medulla_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	HIP1 SNRK PTPN4 KCTD16 CDC42BPA OXR1 THRB NLK	3.69e-06	189	213	8	830d9cd0dd706bce22eb2416f07b2c31c870a05a
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SIRPB2 STAB1 ACSL1 MERTK FMNL1 CSF1R PLXDC2 ARHGAP18	4.31e-06	193	213	8	bd08555f02db8bc903caacae57e80bb91e2556ce
ToppCell	TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6\|TCGA-Prostate / Sample_Type by Project: Shred V9	CLTC POLR1B SMARCA5 ZBED6 SMARCC1 PRKDC KDM1B AQR	4.31e-06	193	213	8	abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SIRPB2 STAB1 ACSL1 MERTK FMNL1 CSF1R PLXDC2 ARHGAP18	4.31e-06	193	213	8	374d0526a071e973c3f43b4564f78f6933bb67ed
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|lung / Disease (COVID-19 only), tissue and cell type	SIRPB2 STAB1 ACSL1 MERTK FMNL1 CSF1R PLXDC2 ARHGAP18	4.65e-06	195	213	8	148fff8c3c9ba45ec36e98dff1be57e3f8294506
ToppCell	Children_(3_yrs)-Immune-monocyte-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SIRPB2 STAB1 XYLT1 ACSL1 MERTK FLT3 CSF1R PLXDC2	4.65e-06	195	213	8	81a28289eda1a8a1a31b7357106f64ac5000e172
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAB1 ACSL1 MERTK FMNL1 FLT3 CSF1R PLXDC2 ARHGAP18	4.65e-06	195	213	8	247803cf58c6d9c561a52aa34e581188ddad197e
ToppCell	(1)_Control_(PBS)-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	CTNNAL1 SNRK ATP8B1 STAB1 CLTC FLT1 FLT4 TEK	4.65e-06	195	213	8	6b5d3ecec0c00ebfc889dc6235390ff53b5c0b6a
ToppCell	COVID-19-Myeloid-Monocytes\|COVID-19 / group, cell type (main and fine annotations)	SIRPB2 STAB1 ACSL1 FMNL1 FLT3 CSF1R PLXDC2 NUMB	4.83e-06	196	213	8	04d710267658ea5601ae2cfb4ed5acb8a29bd8a1
ToppCell	Adult-Immune-monocyte-D122\|Adult / Lineage, Cell type, age group and donor	SIRPB2 STAB1 XYLT1 MERTK FMNL1 FLT3 CSF1R PLXDC2	4.83e-06	196	213	8	16b0acb6157534938ca83d4e909471e33a7d3c52
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HIP1 PDGFRA DGKG RTKN XYLT1 SEMA5A TEK GRM5	4.83e-06	196	213	8	f374cb3ec31c6eef2cef9e07547bfd1e380553af
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIRPB2 INO80D STAB1 ACSL1 MERTK CSF1R PLXDC2 ARHGAP18	4.83e-06	196	213	8	1b7928f4eee94d4bb6ea410bab68a471dba12979
ToppCell	COVID-19-lung-Macrophage_metabolically_active\|lung / Disease (COVID-19 only), tissue and cell type	SIRPB2 INO80D STAB1 ACSL1 MERTK CSF1R PLXDC2 ARHGAP18	4.83e-06	196	213	8	a753d76d764c181eecb0e17a794a2e7d0ff70136
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	HIP1 PDGFRA DGKG RTKN XYLT1 SEMA5A TEK GRM5	4.83e-06	196	213	8	671c380b58d7f634b4fbec38c357d357ea4f3535
ToppCell	COVID-19-lung-Macrophage_CD163hi_MERTKhi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIRPB2 STAB1 ACSL1 MERTK FMNL1 CSF1R PLXDC2 ARHGAP18	4.83e-06	196	213	8	7026c1fc33425e5476063d17c79e4b79356a9e01
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIRPB2 STAB1 ACSL1 MERTK FMNL1 RNF213 CSF1R PLXDC2	5.01e-06	197	213	8	e42910a653a1b5bd90c090e9665a84871ed2873f
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|lung / Disease (COVID-19 only), tissue and cell type	SIRPB2 STAB1 ACSL1 FMNL1 FLT3 RNF213 CSF1R PLXDC2	5.01e-06	197	213	8	a0f8a992282a6d64890f5574c7c9741fcb38dadd
ToppCell	COVID-19-lung-Macrophage_LDB2hi_OSMRhi_YAP1hi\|lung / Disease (COVID-19 only), tissue and cell type	SIRPB2 STAB1 ACSL1 MERTK FMNL1 FLT3 CSF1R PLXDC2	5.01e-06	197	213	8	3896729740d151f0eb845f1961c7b969bfbdd28d
ToppCell	mLN-(4)_Monocyte\|mLN / shred on region, Cell_type, and subtype	SIRPB2 STAB1 ACSL1 MERTK FLT3 ITLN1 CSF1R PLXDC2	5.40e-06	199	213	8	6795ff31f92580195c9db776951f99d647484d24
ToppCell	mLN-Monocyte-Monocyte\|mLN / Region, Cell class and subclass	SIRPB2 STAB1 ACSL1 MERTK FLT3 ITLN1 CSF1R PLXDC2	5.40e-06	199	213	8	dcee372774c169a3048bdaed3734b3215bf8ffad
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-Z\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	STAB1 BLVRB CLTC GBGT1 MERTK CSF1R PLXDC2 ARHGAP18	5.40e-06	199	213	8	994e885b8d1874006302a081d13f1ee881d64612
ToppCell	mLN-(4)_Monocyte-(40)_Monocyte\|mLN / shred on region, Cell_type, and subtype	SIRPB2 STAB1 ACSL1 MERTK FLT3 ITLN1 CSF1R PLXDC2	5.40e-06	199	213	8	bcbb1eee8d79bf670dbe113094c3a292b135ce2f
ToppCell	mLN-Monocyte\|mLN / Region, Cell class and subclass	SIRPB2 STAB1 ACSL1 MERTK FLT3 ITLN1 CSF1R PLXDC2	5.40e-06	199	213	8	241f790cd5d8a9b2451333deecc826a673bae70a
ToppCell	10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	STAB1 BLVRB CLTC GBGT1 MERTK CSF1R PLXDC2 ARHGAP18	5.40e-06	199	213	8	f965eb89d6d023c83154276b8fded490fd89c100
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic-Monocyte_CD14\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SIRPB2 STAB1 XYLT1 ACSL1 FMNL1 FLT3 CSF1R PLXDC2	5.60e-06	200	213	8	5432bdf495431cd26f6e4cd585100f3652588913
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SIRPB2 STAB1 ACSL1 MERTK ABCC5 CSF1R PLXDC2 ARHGAP18	5.60e-06	200	213	8	78d75d381cb2b9a4c9eb7c32a07b014eaee39195
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Monocytic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SIRPB2 STAB1 XYLT1 FMNL1 FLT3 CSF1R PLXDC2 KDM1B	5.60e-06	200	213	8	8872d5fa101d413fb43b4231d476878678543035
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DGKG BCL6 ZBP1 PTPRO FMNL1 CSF1R PRKCD	1.43e-05	164	213	7	cd0794f84dfd346807e2d803723718b7f22e9232
ToppCell	droplet-Lung-21m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4\|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	DGKG BCL6 ZBP1 PTPRO FMNL1 CSF1R PRKCD	1.43e-05	164	213	7	12251a49fd4af32d4edb58046245548c260cf04b
ToppCell	TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-5\|TCGA-Ovary / Sample_Type by Project: Shred V9	RBM12B OBSCN KMT2E INO80D PTPN4 PLXNB1 SMARCC1	1.55e-05	166	213	7	32d2eaf8a5d03881bf74d680825af2d5110b082d
ToppCell	Adult-Endothelial-alveolar_capillary_endothelial_cell_(Cap2;_aerocyte)-D231\|Adult / Lineage, Cell type, age group and donor	OBSCN AIPL1 FLT1 FLT4 CELSR3 PRICKLE2 DISP1	1.61e-05	167	213	7	5af9127bae05768a5164d5708a4ad37edca99324
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIP1 STARD8 PSMA8 ACKR2 FLT1 RGS12 NUMB	1.74e-05	169	213	7	41ad349806b279fbe1374b7e3cc7f146a11adb44
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	HIP1 STARD8 PSMA8 ACKR2 FLT1 RGS12 NUMB	1.74e-05	169	213	7	42782c61592742190ab0cba8a94f8bdf9c278f90
ToppCell	368C-Myeloid-Macrophage-SPP1+_Macrophage_2\|Macrophage / Donor, Lineage, Cell class and subclass (all cells)	KIFBP PIK3R4 RNF138 FLT1 POLR1A RLF FBLIM1	1.74e-05	169	213	7	ea600c63cf9572bc4b3cad6392f67bd0d92c7fc9
ToppCell	E18.5-Immune-Immune_Myeloid-Monocytic-Macrophage-IM\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STARD8 STAB1 BLVRB ZBP1 CLTC RNF213 CSF1R	1.95e-05	172	213	7	c96bd3407911df3e3e6d7a3dba786b11814b9598
ToppCell	droplet-Marrow-BM-1m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL1 ZBP1 PTPRO FMNL1 CSF1R PRKCD PKN1	2.70e-05	181	213	7	89c551de26de047c316c91ac1d97bdf728a33d9e
ToppCell	E18.5-samps-Endothelial-Mature_fetal_endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SNRK FLT1 FLT4 RNF213 TEK RGS12 ARHGAP18	2.80e-05	182	213	7	7af3b2029b7f55b923d5a4b764d4292f4ea48599
ToppCell	E18.5-samps-Endothelial\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SNRK FLT1 FLT4 RNF213 TEK RGS12 ARHGAP18	2.80e-05	182	213	7	e2d799e6e7526176a6fe6515b8fbe4d83d3a3ea1
ToppCell	Control-Endothelial-Endothelial-Activated_Alv_Cap\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MBOAT2 PTPN4 FLT4 RNF213 THRB PRICKLE2 NUMB	2.90e-05	183	213	7	e81c142770f44fd902b0631bc360c5b5339d4c75
ToppCell	Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_E_(THEMIS)-Glut_D_(IT_RORB_THEMIS_LINC00507)_6\|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CTNNAL1 SYN3 DGKG KCTD16 ENC1 PLXDC2 CTNNA2	3.00e-05	184	213	7	9a185e6ea86bbfbb48bfe88650a8c05ceba78d7f
ToppCell	droplet-Marrow-BM-1m-Myeloid\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ACSL1 ZBP1 PTPRO FMNL1 CSF1R PRKCD PKN1	3.00e-05	184	213	7	69348c9237e44f7752ac01f60e733ad41580fdb8
ToppCell	PBMC-Mild-cDC_9\|Mild / Compartment, Disease Groups and Clusters	ADAR ACSL1 FLT1 POLR1A RNF213 CSF1R ZBED6	3.00e-05	184	213	7	2e0c9a2c40c892a2d435eafb31f1f838de9baf15
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIP1 PDGFRA DGKG RTKN XYLT1 SEMA5A TEK	3.11e-05	185	213	7	2e1766f1a972fecd670daaaf7eb2d3a404f121e7
ToppCell	Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Oligo-OPC\|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	HIP1 PDGFRA DGKG RTKN XYLT1 SEMA5A TEK	3.11e-05	185	213	7	7aaa8335b40927e3e8fdcede807cd521fc213a0d
ToppCell	droplet-Bladder-nan-24m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HIP1 STAB1 KCNJ2 FLT1 FLT4 HUS1 TEK	3.11e-05	185	213	7	90caab8d9361a541c5d5121c97c3f1cdffeeae4a
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 STAB1 CLTC MERTK CSF1R PLXDC2 NUMB	3.56e-05	189	213	7	6dd4ec5ce4beb856f0d2d1654e3c4676d1d63736
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 STAB1 CLTC MERTK CSF1R PLXDC2 NUMB	3.56e-05	189	213	7	875df61ee48baa5142ba4d2427bdec1c53e5a828
ToppCell	facs-Lung-nan-3m-Endothelial-Capillary_Aerocyte_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 STAB1 PTPN4 MERTK RGS12 PRICKLE2 NUMB	3.56e-05	189	213	7	09dd2b3d89416192e84abe302a6237b8f3fdcb6e
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_capillary-CAP2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	SYN3 MBOAT2 FLT1 FLT4 CDC42BPA PRICKLE2 DISP1	3.56e-05	189	213	7	b6b4da51bc7f2c13a2f940540fdc61027d084835
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	SIRPB2 STAB1 ACSL1 FMNL1 CSF1R PLXDC2 ARHGAP18	3.56e-05	189	213	7	7ccea2df93bb4b37417bbc8f6c85a61ece95211a
ToppCell	facs-Brain_Myeloid-Striatum-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 STAB1 CLTC MERTK CSF1R PLXDC2 NUMB	3.56e-05	189	213	7	3ae479ec7e00c57127cbe51a398329b10ca9848c
ToppCell	COVID-19-Heart-Macrophage\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIRPB2 STAB1 ACSL1 MERTK CSF1R PLXDC2 ARHGAP18	3.56e-05	189	213	7	2586f4088721c5debec86c2b211b739fd33713eb
ToppCell	facs-Brain_Myeloid-Striatum-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 STAB1 CLTC MERTK CSF1R PLXDC2 NUMB	3.56e-05	189	213	7	97ef5215d841ff366a3e3682cd9bd04100cbfde0
ToppCell	(0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells\|World / Stress and Cell class	CTNNAL1 SNRK STAB1 FLT1 FLT4 ENC1 TEK	3.68e-05	190	213	7	ff083168d609957d00888f31b3488d6d56c902b4
ToppCell	Control-Myeloid\|Control / group, cell type (main and fine annotations)	SIRPB2 STAB1 ACSL1 MERTK CSF1R PLXDC2 ARHGAP18	3.81e-05	191	213	7	9c4acc5f3c2f9c0c5520863bb22f391774372347
ToppCell	Fetal_29-31_weeks-Immune-interstitial_macrophage_(C1Q_positive)-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	STAB1 ACSL1 PTPRO MERTK CSF1R DHRS9 ARHGAP18	3.81e-05	191	213	7	24d75b7e1d6fb9d24aa7844f584ee888a449841f
ToppCell	droplet-Heart\|droplet / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 OBSCN SNRK STAB1 FLT1 TEK FBLIM1	3.94e-05	192	213	7	67a7e07a11091120edbccf739836235c422ec9c6
ToppCell	PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STARD8 SYN3 PTPN4 ACKR2 FLT1 FLT4 RGS12	3.94e-05	192	213	7	2360824910cd471c8286ca369ba144d90d984602
ToppCell	facs-Brain_Myeloid-Hippocampus-3m\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 STAB1 CLTC SMARCA5 CSF1R PLXDC2 NUMB	4.07e-05	193	213	7	a4f91bca5eaa985982d33a528f7566ffde154d47
ToppCell	facs-Liver-Non-hepatocytes-3m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 SNRK STAB1 MERTK FLT1 FLT4 TEK	4.07e-05	193	213	7	8084fa0ce61f1f4a728423b6b81df04eaa5af5b6
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 STAB1 CLTC SMARCA5 CSF1R PLXDC2 NUMB	4.07e-05	193	213	7	b39d7feaac4ff8f7409cd3d15e8f3c6391367275
ToppCell	facs-Brain_Myeloid-Hippocampus-3m-Myeloid\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CLASP2 STAB1 CLTC SMARCA5 CSF1R PLXDC2 NUMB	4.07e-05	193	213	7	06b65110db974f4ef90d3511ff34428976a52c9c
ToppCell	Control-Endothelial-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTNNAL1 MBOAT2 FLT1 TEK PRICKLE2 NUMB ARHGAP18	4.07e-05	193	213	7	aff0649c73c634bc6ff0dc7759b4693a9236bf05
ToppCell	Control-Endothelial\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	CTNNAL1 MBOAT2 FLT1 TEK PRICKLE2 NUMB ARHGAP18	4.07e-05	193	213	7	c5f9fe03e64c211d4bcd4959e5b32f14841e336a
ToppCell	facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lung\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 SNRK STAB1 FLT1 TEK PRICKLE2 NUMB	4.20e-05	194	213	7	f159ef8541d75a4e98468947f231bb463bec922c
ToppCell	control-Myeloid-Neutrophils_2\|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	BCL6 ADAR ACSL1 ZBP1 RNF213 DHRS9 ZC3HAV1	4.20e-05	194	213	7	267e213e8efe53aadfe553a2ca010a0e3b4b8939
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STARD8 SYN3 PTPN4 ACKR2 FLT1 FLT4 RGS12	4.20e-05	194	213	7	fc40ab57be3a15c043e3414c2c678c1dc52207c8
ToppCell	Adult-Immune-interstitial_macrophage_(C1Q_positive)-D231\|Adult / Lineage, Cell type, age group and donor	STAB1 ACSL1 MERTK ABCC5 CSF1R DHRS9 ARHGAP18	4.20e-05	194	213	7	800d3d7a9e864d2d6a100a4e4af22f45d5790a8d
ToppCell	PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-CAP2-CAP2_mature\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	STARD8 SYN3 PTPN4 ACKR2 FLT1 FLT4 RGS12	4.20e-05	194	213	7	50fa7c7940b113427c87fbdb9057fef8e1ce52c5
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	HIP1 RTKN SUPT5H MERTK CDC42BPA ARHGEF5 SPG11	4.20e-05	194	213	7	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	HIP1 RTKN SUPT5H MERTK CDC42BPA ARHGEF5 SPG11	4.20e-05	194	213	7	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	(4)_Endothelial_cells-(42)_EC-sinusoidal\|World / Cell class and subclass of bone marrow stroma cells in homeostatis	SNRK STAB1 CLTC FLT1 FLT4 ENC1 TEK	4.20e-05	194	213	7	4428b472c2042f88eae028b1770767512a515b75
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-M2_Macrophage\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	STAB1 ACSL1 MERTK FMNL1 CSF1R PLXDC2 ARHGAP18	4.20e-05	194	213	7	45708cb2cafde10bf4e4798b81d47c3b1f6aaa14
ToppCell	RA-08._Macrophage\|RA / Chamber and Cluster_Paper	SIRPB2 STAB1 ACSL1 MERTK THRB PLXDC2 ARHGAP18	4.20e-05	194	213	7	ac26e5c71d5069622de72fa25a9c920887ac2c19
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Immune-Myeloid\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	SIRPB2 STAB1 ACSL1 MERTK FMNL1 CSF1R PLXDC2	4.34e-05	195	213	7	91a3c439f10c03c5d51d904f512b6a08040edc76
ToppCell	(0)_Normal/No_Treatment-(1)_VE-Cad+_vascular_cells\|(0)_Normal/No_Treatment / Stress and Cell class	SNRK STAB1 CLTC FLT1 FLT4 ENC1 TEK	4.34e-05	195	213	7	e8ab3122f81cb22920becd6611cbd9f00db19d50
ToppCell	COVID-19-Myeloid-Monocyte-derived_macrophages\|COVID-19 / group, cell type (main and fine annotations)	SIRPB2 STAB1 ACSL1 MERTK CSF1R PLXDC2 ARHGAP18	4.34e-05	195	213	7	c172c5599379c29123340621a36bfb1fc90c2115
ToppCell	background-Endothelial_cells\|World / Sample and Cell Type and Tumor Cluster (all cells)	INO80D STAB1 RIMKLB FLT1 FLT4 TEK PLXDC2	4.34e-05	195	213	7	c7d60dabfc7cb310e002cab10003dadfcc34fe33
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic-intermediate_monocyte\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SIRPB2 STAB1 ACSL1 BLVRB FLT3 CSF1R PLXDC2	4.34e-05	195	213	7	403d874198a7bde626b0d0b4efad8dbb34060761
ToppCell	facs-Lung-nan-3m-Endothelial\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 SNRK STAB1 FLT4 TEK PRICKLE2 NUMB	4.34e-05	195	213	7	7f9b7f15006610ad591063d90e90367bd6083c7f
ToppCell	background-Endothelial_cells\|background / Sample and Cell Type and Tumor Cluster (all cells)	DGKG STAB1 RIMKLB FLT1 FLT4 TEK PLXDC2	4.49e-05	196	213	7	e6fb0bfab1779ec64a8c35d01519eaafbf62e977
ToppCell	10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_monocytic\|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	SIRPB2 STAB1 ACSL1 BLVRB FLT3 CSF1R PLXDC2	4.49e-05	196	213	7	f943519bff51c3094776fd45889dadf9062c8379
ToppCell	COVID-19-lung-Capillary_1\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SYN3 SNRK MBOAT2 FLT1 TEK PRICKLE2 ARHGAP18	4.49e-05	196	213	7	ac28e9be288af6f00a841aea4ce4b99aed6b4505
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 SNRK STAB1 MERTK FLT1 FLT4 TEK	4.63e-05	197	213	7	a6aaa6faea348291023f0bc4b0f83fbc67d91da6
ToppCell	Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_capillary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	STARD8 SYN3 MBOAT2 FLT1 TEK PRICKLE2 ARHGAP18	4.63e-05	197	213	7	81718164c9802ee20c860ffbda7e62d5e9a76f16
ToppCell	facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STARD8 SNRK STAB1 MERTK FLT1 FLT4 TEK	4.63e-05	197	213	7	deefb492b5f0e6014144bd465c4a6ae4206e8739
ToppCell	Sepsis-ICU-SEP-Lymphocyte-T/NK-Treg\|ICU-SEP / Disease, condition lineage and cell class	EFCAB5 OBSCN GPATCH4 TSTD1 FBXO10 ARHGEF5 TET1	4.63e-05	197	213	7	c3ee2d522fbfe67069ddba2d1abfc4f5ca230c26
ToppCell	COVID-19-lung-Macrophage_VCANhi_FCN1hi\|COVID-19 / Disease (COVID-19 only), tissue and cell type	SIRPB2 STAB1 ACSL1 FMNL1 RNF213 CSF1R PLXDC2	4.78e-05	198	213	7	ea34096bee852a7e996f097fa279381afa8f86ff
ToppCell	Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_CHIT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	OR13C5 PTPRO MERTK ABCC5 CSF1R DHRS9 ARHGAP18	4.78e-05	198	213	7	0b41b3d6c2db795320e8b65d40d85fb8b618cc34
Drug	Sunitinib	PDGFRA FLT1 FLT3 FLT4 CSF1R	3.40e-09	8	209	5	DB01268
Drug	5H-benzo(4,5)cyclohepta(1,2-b)pyridin-5-one	PDGFRA MERTK FLT1 FLT3 FLT4	2.50e-07	16	209	5	ctd:C561052
Drug	Beta-Escin [11072-93-8]; Down 200; 3.2uM; PC3; HT_HG-U133A	SNRK BCL6 PLXNB1 RARS1 APC ECPAS EDEM3 IPO9 THRB PPP3R1 DHRS9	1.90e-06	194	209	11	3807_DN
Drug	pazopanib	PDGFRA FLT1 FLT4 THRB	3.22e-06	12	209	4	ctd:C516667
Drug	axitinib	PDGFRA FLT1 FLT3 FLT4 IFNA4 PRKDC	3.37e-06	45	209	6	CID006450551
Drug	Bromopride [4093-35-0]; Up 200; 11.6uM; PC3; HT_HG-U133A	HIP1 ACTN2 ZNF235 STAB1 FMNL1 TRIM46 APC CSF1R DHRS9 SOS2	1.55e-05	198	209	10	4278_UP
Drug	Famotidine [76824-35-6]; Up 200; 11.8uM; HL60; HG-U133A	ADAR BLVRB GOLGA1 SMARCA5 SFSWAP CAPN3 PPM1B PPP3R1 DHRS9 N4BP1	1.55e-05	198	209	10	2029_UP
Drug	Nitrendipine [39562-70-4]; Down 200; 11uM; MCF7; HT_HG-U133A	HIP1 INO80D MERTK PLXNB1 FLT4 APC SLC1A7 RGS12 N4BP1 SOS2	1.55e-05	198	209	10	5405_DN
Drug	AC1O3GBZ	TONSL POLN FLT1 ABCC5 IFNA4	1.86e-05	36	209	5	CID006327751
Drug	Azitidin	ZBTB6 TONSL POLN FLT1 ABCC5 IFNA4 CSF1R PRKCD ZC3HAV1	2.74e-05	169	209	9	CID000005726
Disease	cerebral cavernous malformation (implicated_via_orthology)	CDC42BPA RNF213 CDC42BPB	4.94e-05	11	201	3	DOID:0060669 (implicated_via_orthology)
Disease	lifestyle measurement, anxiety disorder measurement	GBGT1 ACKR2 RNF138 GRIK2 PPP2R2C SMARCC1	3.64e-04	137	201	6	EFO_0007795, EFO_0010724
Disease	Cone-Rod Dystrophies	AIPL1 NUMB	4.56e-04	5	201	2	C4085590
Disease	Metastatic melanoma	PDGFRA FLT4 PKN1 PRKDC	5.06e-04	54	201	4	C0278883
Disease	monocyte percentage of leukocytes	BCL6 C11orf40 PXYLP1 ACKR2 FLT3 CDC42BPA POLR1A CAPN3 ABCC5 AGBL3 NLRP6 THRB CSF1R PRKDC	5.23e-04	731	201	14	EFO_0007989
Disease	Pleocytosis	FLT3 APC	6.80e-04	6	201	2	C0151857
Disease	Leukocytosis	FLT3 APC	6.80e-04	6	201	2	C0023518
Disease	obsolete_Fms-related tyrosine kinase 3 ligand measurement	FLT3 NLRP6	9.48e-04	7	201	2	EFO_0010594
Disease	carcinoma (implicated_via_orthology)	FLT1 FLT3 FLT4 CSF1R	9.65e-04	64	201	4	DOID:305 (implicated_via_orthology)
Disease	Drug habituation	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C0013170
Disease	Drug abuse	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C0013146
Disease	Prescription Drug Abuse	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C4316881
Disease	Substance-Related Disorders	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C0236969
Disease	Drug Use Disorders	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C0013222
Disease	Drug Dependence	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C1510472
Disease	Substance Dependence	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C0038580
Disease	Substance Use Disorders	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C0038586
Disease	Organic Mental Disorders, Substance-Induced	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.17e-03	115	201	5	C0029231
Disease	Substance abuse problem	XYLT1 TMPRSS7 GRIK2 GRM5 PRPF4	1.21e-03	116	201	5	C0740858
Disease	trans fatty acid measurement, trans-16:1n-7 fatty acid measurement	DIAPH3 TEK	1.26e-03	8	201	2	EFO_0006821, EFO_0006822
Disease	Leydig cell tumor (is_marker_for)	PDGFRA FLT1	1.26e-03	8	201	2	DOID:2696 (is_marker_for)
Disease	opportunistic bacterial infectious disease (implicated_via_orthology)	SMARCC1 SMARCC2	1.61e-03	9	201	2	DOID:0050340 (implicated_via_orthology)
Disease	Coffin-Siris syndrome (implicated_via_orthology)	SMARCC1 SMARCC2	1.61e-03	9	201	2	DOID:1925 (implicated_via_orthology)
Disease	retinal detachment, retinal break	SFSWAP GRM5 PLXDC2	1.74e-03	35	201	3	EFO_0005773, EFO_0010698
Disease	medulloblastoma (is_implicated_in)	APC ELP1	2.00e-03	10	201	2	DOID:0050902 (is_implicated_in)
Disease	decadienedioic acid (C10:2-DC) measurement	HEATR4 NUMB	2.00e-03	10	201	2	EFO_0800598
Disease	abdominal aortic calcification measurement	PIK3R4 PLXDC2	2.00e-03	10	201	2	EFO_0010272
Disease	Global developmental delay	KMT2E RARS1 OXR1 SMARCC2 CTNNA2	2.22e-03	133	201	5	C0557874
Disease	neuropsychological test	PXYLP1 CAPN5 FLT1 FAM135B VANGL2 VPS41	2.38e-03	197	201	6	EFO_0003926
Disease	pneumococcal bacteremia	LAMB4 OR6P1	2.44e-03	11	201	2	EFO_1001925
Disease	granulocyte percentage of myeloid white cells	BCL6 ACKR2 FLT3 CAPN3 NLRP6 CSF1R PRKDC	2.51e-03	268	201	7	EFO_0007997
Disease	Mesothelioma	GPC3 ITLN1 APC	2.74e-03	41	201	3	C0025500
Disease	Pathological accumulation of air in tissues	PPP2R2A PPP2R2C	2.91e-03	12	201	2	C0013990
Disease	autosomal dominant cerebellar ataxia (implicated_via_orthology)	PPP2R2A PPP2R2C	2.91e-03	12	201	2	DOID:1441 (implicated_via_orthology)
Disease	Spina Bifida	PDGFRA VANGL2	2.91e-03	12	201	2	C0080178
Disease	Status Dysraphicus	PDGFRA VANGL2	2.91e-03	12	201	2	C0038219
Disease	Intestinal Neoplasms	APC PRKCD	2.91e-03	12	201	2	C0021841
Disease	Intestinal Cancer	APC PRKCD	2.91e-03	12	201	2	C0346627
Disease	thyroid gland carcinoma (is_marker_for)	FLT1 FLT4	2.91e-03	12	201	2	DOID:3963 (is_marker_for)
Disease	Rachischisis	PDGFRA VANGL2	2.91e-03	12	201	2	C0266508
Disease	Adenocarcinoma of lung (disorder)	FLT1 APC SMARCC1 PRKDC SLC4A4 SOS1	2.97e-03	206	201	6	C0152013
Disease	Coffin-Siris syndrome	SMARCA1 SMARCC2	3.43e-03	13	201	2	C0265338
Disease	fatty acid measurement, fetal genotype effect measurement, breast milk measurement	DIAPH3 FAM135B	3.43e-03	13	201	2	EFO_0005110, EFO_0007959, EFO_0009092
Disease	X-24588 measurement	HEATR4 NUMB	3.43e-03	13	201	2	EFO_0800898
Disease	response to beta blocker	SNRK GRM5 LONRF2	3.58e-03	45	201	3	EFO_0007766
Disease	Intellectual Disability	KIFBP KMT2E ALG14 CACNA1G RARS1 OXR1 APC SMARCC2 CTNNA2	3.72e-03	447	201	9	C3714756
Disease	non-high density lipoprotein cholesterol measurement	HIVEP1 ATP8B1 ZNF235 KCNJ2 SPINDOC GRIK2 THRB CSF1R PLXDC2 TYW1B PCCB GEN1	3.74e-03	713	201	12	EFO_0005689
Disease	aspartate aminotransferase measurement	WWC3 OBSCN ATP8B1 MERTK TRIM46 RNF213 HARS2 PPP2R2A IPO9 CSF1R CTNNA2 SLC4A4 SOS1 SOS2	3.77e-03	904	201	14	EFO_0004736
Disease	fatty acid measurement, breast milk measurement, parental genotype effect measurement	DIAPH3 FAM135B	3.98e-03	14	201	2	EFO_0005110, EFO_0005939, EFO_0009092
Disease	Adenocarcinoma of large intestine	APC CDC42BPB PKN1 PRKDC	4.26e-03	96	201	4	C1319315
Disease	anemia (implicated_via_orthology)	APC SLC4A4	4.57e-03	15	201	2	DOID:2355 (implicated_via_orthology)
Disease	Tourette syndrome	XYLT1 FLT3 ZNF577	4.82e-03	50	201	3	EFO_0004895
Disease	alpha fetoprotein measurement	RGS12 TET1 DHRS9 GEN1	4.93e-03	100	201	4	EFO_0010583
Disease	central nervous system disease (implicated_via_orthology)	SMARCA5 SMARCA1	5.20e-03	16	201	2	DOID:331 (implicated_via_orthology)
Disease	smoking status measurement	SNRK ACTN2 ADAR INO80D STAB1 XYLT1 DIAPH3 CDC42BPA POLR1A GRIK2 GRM5 CDC42BPB PPP2R2C PRICKLE2 SMARCC1 CTNNA2	6.09e-03	1160	201	16	EFO_0006527
Disease	Hemangiosarcoma	FLT1 TEK	6.57e-03	18	201	2	C0018923
Disease	factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement	CAPN3 GYS2 PCCB	6.62e-03	56	201	3	EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791

Protein segments in the cluster

Peptide	Gene	Start	Entry
FCITHDMTPKAFLER	VANGL2	426	Q9ULK5
VAFMLCRKDAVVSFG	ACKR2	31	O00590
MDEVAGILAARHCKT	ACOT7L	176	Q6ZUV0
DMRAAALCDKHSKLF	PPP2R2C	251	Q9Y2T4
FMKFVSEDLHRCALL	AGBL3	26	Q8NEM8
SRVIFHFRTMKCDEE	AIPL1	31	Q9NZN9
GLMDHEDFRACLISM	ACTN2	771	P35609
MRASALCDRHSKLFE	PPP2R2A	256	P63151
FERVVECVMLCHGAK	ACSL1	326	P33121
DHAPFSSIRGEKCEM	ARHGEF5	1441	Q12774
DAVRRAVDAMNKHGC	GYS2	86	P54840
VCSHGRAKMEGNIFR	FBXO10	446	Q9UK96
ISKHDLGHFMLRCLT	BLVRB	176	P30043
PAFHIAGDACLQRKM	ANKRD30A	1221	Q9BXX3
DRISERAGHKCMATE	EHMT2	436	Q96KQ7
MCSHFDNDEIKRLGR	PPP3R2	11	Q96LZ3
MEIAEGCFRHIKKIF	AQR	991	O60306
TAADMEARLACGLVK	CAPN5	236	O15484
MCSHFDADEIKRLGK	PPP3R1	11	P63098
HGVTADALVMLAKAC	FBXL6	231	Q8N531
CRVETLSMSGKILFH	ALG14	176	Q96F25
HELKMGSADERLVTC	DIAPH3	181	Q9NSV4
LFMKRIDIAGLGHCD	DHX32	431	Q7L7V1
LRIEAHKRGSVFMCS	CBLL2	101	Q8N7E2
KVLFNHLMGEAGCRS	DISP1	1461	Q96F81
CHGLVIFAGADTKIM	ATP8B1	306	O43520
SAADLCKLAMIHVFT	POLN	771	Q7Z5Q5
LKCHRSFMGSRFIEV	RBM12B	211	Q8IXT5
SAIEKHFLDCGSIMA	RBM34	301	P42696
GLVAVCAVHGIFMDR	OTOR	11	Q9NRC9
CAVHGIFMDRLASKK	OTOR	16	Q9NRC9
EIRLVDDAFGKICHM	INTS4	276	Q96HW7
IKASCERHSGELMLL	PTPN4	586	P29074
SHNAVIAMRDGKLCL	KCNJ2	196	P63252
GHNVFKERISDMCKE	MCM2	211	P49736
MEFLASKNCVHRDLA	PDGFRA	806	P16234
IVKICDFGLARDIMH	PDGFRA	831	P16234
KAEMDAAIASCKRAF	ALDH6A1	76	Q02252
VEGRKKAFATCSSHM	OR2T1	281	O43869
LVASVHENDMRGKCT	ITLN1	81	Q8WWA0
FKDMSAKEGICIAHS	GRM5	231	P41594
VVLKFMSCRESEAFH	GOLGA1	701	Q92805
MSCRESEAFHLIKAV	GOLGA1	706	Q92805
ITSLACEIHDGMFRK	MBOAT2	141	Q6ZWT7
KHLERAFDMLSECGF	KCTD16	231	Q68DU8
EMAVFSCEAHNDKGL	MERTK	256	Q12866
LDRDGHIKIADFGMC	PRKCD	481	Q05655
NTTDHLKFSKDCGRM	GPC3	241	P51654
FGTLVGKARMTLHCA	CFAP65	516	Q6ZU64
CGFAAMKDVRTGSHE	EDEM3	441	Q9BZQ6
SDVECLMGRLQHTFK	ENOX2	571	Q16206
TCHGIDFMRDGKSII	CFAP52	376	Q8N1V2
IQKSCAFAMGHLVRT	ECPAS	1416	Q5VYK3
EMLLQACEGRTAHKA	GPATCH4	146	Q5T3I0
FMDACTLADHKLGRD	PLXNB1	2016	O43157
GLRKVNHFFCEMLSL	OR2V2	171	Q96R30
LREHKAISFEGCMTQ	OR4K3	86	Q96R72
SKFHGLEMCVDARTF	KMT2E	386	Q8IZD2
DAMVEFVKLLNRCCH	ACBD3	156	Q9H3P7
GLMFARCGAHEKALS	ELP1	1006	O95163
MLDHGKFLDCVVRAG	KLHL40	26	Q2TBA0
SMASDCRVFLGKKDH	LCN15	41	Q6UWW0
TGTKRFGMCLSAEHA	LONRF2	571	Q1L5Z9
AHPAIDAMLRKDSCA	ASIC3	351	Q9UHC3
ECRSFEHALMLFGKD	MIER3	286	Q7Z3K6
NGHIRLADFGSCLKM	CDC42BPB	211	Q9Y5S2
SLEAMRTACEGAKAH	NLK	361	Q9UBE8
HFTCEILAVMKLACA	OR13C5	176	Q8NGS8
HFTCEILAVMKLACA	OR13C2	176	Q8NGS9
ALGKCMDLHEKDFSL	PARP4	506	Q9UKK3
TGLLGAHFVCDRMKI	UQCRC1	351	P31930
KKHLQMARECGAGTF	PTPRO	846	Q16827
RFLHKDMAGSCVDAV	OBSCN	796	Q5VST9
VEHRCADFGMAADKN	PCCB	86	P05166
AMTGHAGSFIKECRE	PRICKLE2	456	Q7Z3G6
DQLSGRDFCHSKKMT	OXR1	291	Q8N573
RHCKILILDEATAAM	ABCC5	1346	O15440
EVKEAFRKTVMGRCH	OR6P1	296	Q8NGX9
DCGESALKKFDHMLL	CPLANE2	116	Q9BU20
AKGMEFLEFKSCVHR	FLT3	796	P36888
KICDFGLARDIMSDS	FLT3	826	P36888
MTFHRKCELSTLCDG	DGKG	371	P49619
RQMFAELFLHCDHGK	EFCAB5	386	A4FU69
MAFLASKNCIHRDVA	CSF1R	766	P07333
ISMHKFGERCDLIQE	KDM1B	456	Q8NB78
HCRDEMAAARGALKK	CTNNA2	201	P26232
CESAHKNKEGVFDRM	CTNNAL1	251	Q9UBT7
DALAAGIMAHICRKD	SLC1A7	466	O00341
GIMAHICRKDFARDT	SLC1A7	471	O00341
ECMHKLGNSCEFRLL	ADAR	621	P55265
ILGMHLFGCKFASER	CACNA1G	881	O43497
TRGCHMAILADKANG	GBGT1	276	Q8N5D6
ASLLAMCAGAEVVHR	BRAWNIN	16	Q69YU5
AALCDKNAHVRMAAA	HEATR4	536	Q86WZ0
VGDICSFALMDVKRH	ATG9B	666	Q674R7
EQFRAHKTVLMACSG	BCL6	41	P41182
FTCIEVKFHLERQMG	GLRA2	241	P23416
AGICHKVSTFAMRSL	MBLAC2	251	Q68D91
FKEVCGEQHRFEKLM	FMNL1	296	O95466
MKAHVRRGTAFCQLE	DNAAF4	366	Q8WXU2
DDSLVKELIRMCSHG	EFHC1	611	Q5JVL4
KDAFKIECMGRNFHE	FBLIM1	316	Q8WUP2
GRSHFKSVLRECLHM	GEN1	106	Q17RS7
LCEEHAKKMDNFLRG	INO80D	506	Q53TQ3
IHEACMLALGSVKAI	IPO9	446	Q96P70
CERLIISMSAKLHDG	LAMB4	751	A4D0S4
VGDVTAKRMSCHAVA	ENC1	521	O14682
FHSARIEMCKTALKD	FAM135B	1321	Q49AJ0
SHKDFIGCMRDLHID	CELSR3	1686	Q9NYQ7
HQCGMSEKAIEKFIR	C6orf89	26	Q6UWU4
AHRKLMDLECSRDGL	EXOC3	141	O60645
VIFDCSHEMAAGILK	GRIK2	226	Q13002
DLKTHGFTLESCRSM	CAPN3	686	P20807
RRDMKAFGVHVSCIE	DHRS9	191	Q9BPW9
HTKFVRDMIREVCGF	RPL36	36	Q9Y3U8
DVRKGACASHVSTMA	DBNL	91	Q9UJU6
INKLCFMEARHCLSA	KIFBP	261	Q96EK5
RHFGCMVSERVKQEA	NLRP6	561	P59044
TLMEKCDVTDLGLHR	PCDH11Y	766	Q9BZA8
HFSCEILAVMKLACA	OR13C9	176	Q8NGT0
EHMGIARLACASIKV	OR52E8	186	Q6IFG1
ESRGMHICEDAVKRL	NUMB	51	P49757
AALRGHFCLSSDKMV	OIP5	156	O43482
DHEIRMREGACKLLA	RTKN	46	Q9BST9
LLCEAVAAVMAKGFD	RARS1	636	P54136
EMFGGLDICAVKAVH	SYN3	341	O14994
HTGEFMCLVVVSDRR	STK11IP	821	Q8N1F8
AKMHAIIERTASFVC	SFSWAP	206	Q12872
RMVVAAGKRFCGEHA	TRMT13	31	Q9NUP7
SFRHCQLDVGREMKL	TRIM46	406	Q7Z4K8
FHCMAGREGLVDTAV	POLR1A	966	O95602
VISCFKRHGAKGMDT	HARS2	81	P49590
ERHIFLFDGLMISCK	SOS2	456	Q07890
EDRFLICMLHKMGFD	SMARCA1	966	P28370
TGRCIMFLEGHLKEI	PRPF4	396	O43172
LAQMGRISHFSCLKD	IFNA16	41	P05015
MKFRAKIVDGACLNH	HUS1	1	O60921
VMEDKSDRPVCRHFA	PRR3	151	P79522
GRGKFEELMVCSHEI	HIP1	896	O00291
CLSHEEFLGVLKNRM	MICU2	381	Q8IYU8
KADLAAAGVMLLCHF	PLXDC2	6	Q6UX71
HVFCRKCFLTAMRES	RNF138	36	Q8WVD3
KAGSRRLTELHGCMD	SIRT4	151	Q9Y6E7
MALKAEGAALDCFEV	SPINDOC	1	Q9BUA3
TRNGCVDMEHFKVIK	PXYLP1	311	Q8TE99
MCVHFFDVERAAKAA	WDR13	431	Q9H1Z4
HKGSRDNMSIVLVCF	PPM1B	281	O75688
ENGGMFVCKTRHLVL	SUPT5H	631	O00267
KRTDGLHFRTICMEA	SI	1426	P14410
MCEKRILAAVTSAGH	PKN1	661	Q16512
LAQMGRISHFSCLKD	IFNA4	41	P05014
AFHVTCAFDRGLEMK	JADE1	336	Q6IE81
KHERHIFLFDGLMIC	SOS1	456	Q07889
MNGHIRLADFGSCLK	CDC42BPA	211	Q5VT25
ATGHLFQEVRCMKLV	SNRK	56	Q9NRH2
TGDVCAVMRVHAFLE	SMARCC1	516	Q92922
AGDVCAIMRVHAFLE	SMARCC2	491	Q8TAQ2
FGHLCAMEVAKIRDS	STARD8	996	Q92502
SSVEEKRCGEFNMFH	SEMA5A	956	Q13591
MSCDHLKGRSNVLVF	TET1	811	Q8NFU7
MGVDFDVKTFCHNLR	BRPF1	1	P55201
HAVTKLCMAGRDITE	ACTRT1	176	Q8TDG2
MKAARAGHLCTVQFL	ANKHD1	606	Q8IWZ3
CVLMKLSFDEEHRHA	APC	451	P25054
VDGKEFRLAQMCGLH	CLTC	1261	Q00610
CEIFTRMFADPHGKR	CLASP2	696	O75122
AGKNCMDRVLLHVDV	C11orf40	196	Q8WZ69
ATRQKMRECHGLVDA	PKP3	491	Q9Y446
KRAMDIFSAGCVIAE	PIK3R4	236	Q99570
RPGDSEKHNMIALCF	SPG11	2211	Q96JI7
DDACHASFLRVSKMR	RNF213	3571	Q63HN8
GMFHALFRICKEEGV	SLC25A14	86	O95258
HCVRFDGLSEHSEMK	SIRPB2	126	Q5JXA9
KDAADFAICMHAGRL	ZNF451	951	Q9Y4E5
GEVFSEQFCLKTHMR	ZNF562	131	Q6V9R5
KQGLDRLFLECDAHM	XYLT1	461	Q86Y38
ECGKSFRQMSDLVKH	ZNF48	116	Q96MX3
CTAAFATKDRLRTHM	VEZF1	266	Q14119
GEAAQRIHMKSCFLE	ZBP1	316	Q9H171
RIHMKSCFLEDATIG	ZBP1	321	Q9H171
LHMVIAEGVGRFESC	RGS12	91	O14924
MAAHASRDRVIKNCI	MIX23	61	Q4VC31
EGRQKALSTCSAHFM	OR4E2	231	Q8NGC2
APISFKTRAEALHMC	RLF	1526	Q13129
AASGRLMCHFKLVAI	TMPRSS7	266	Q7RTY8
GSDHELMLRCTKGRE	PYROXD1	431	Q8WU10
CAVAHRKIGERLAEM	TONSL	66	Q96HA7
CRECGKAFAHMSVLI	ZNF577	356	Q9BSK1
IGACHASRFLHMKVE	THRB	431	P10828
VARGMEFLASRKCIH	FLT4	1021	P35916
MCTDLHFQEKRAGVF	STAB1	2196	Q9NY15
DSDITVLRHLEKMGC	RIMKLB	86	Q9ULI2
SKGMRHFCLISEQLV	TMEM168	346	Q9H0V1
FMGRTCEKACELHTF	TEK	246	Q02763
DAASCMTVHDKFLAL	VPS41	46	P49754
LFMCHALGLKSSEQR	ARHGAP18	486	Q8N392
AMSHGNKEEFSCRGI	ZC3H12B	201	Q5HYM0
IAMHDIIAAEKCFGT	PRKDC	1301	P78527
FCEHKSIENMLVAAR	ZBED6	596	P86452
KECGMAFRQTAHLTR	ZFP82	201	Q8N141
ECGKAFARKSTLIMH	ZNF484	696	Q5JVG2
VCTEAGMFAIRADHD	PSMC6	346	P62333
HSLFELRTCMEKGSI	SLC4A4	156	Q9Y6R1
GASFVKSCTVHMLGR	ZNF304	151	Q9HCX3
TKILCAHGGRMALDA	ZC3HAV1	11	Q7Z2W4
VKAERFEEGMTVKHC	TYW1	466	Q9NV66
VRKICALDDHVCMAF	PSMA8	61	Q8TAA3
EDRFLICMLHKLGFD	SMARCA5	951	O60264
CVHRGADFAKMRTTT	POLR1B	471	Q9H9Y6
VARGMEFLSSRKCIH	FLT1	1006	P17948
EMATLHKAGLRCFSL	ZNF235	86	Q14590
MLFGVKDIALLEHGC	PNMA8C	1	A0A1B0GUJ8
CHAAGEAMSVRSKAL	HIVEP1	926	P15822
AICTGEKERRDLMHS	WWC3	156	Q9ULE0
MEKCHSLVGSSVRDD	ZNF850	106	A8MQ14
RFEEGMTVKHCALSL	TYW1B	406	Q6NUM6
ASDICHDRAVKFLMS	VPS54	606	Q9P1Q0
CGKAFISLTSVDRHM	ZNF670	146	Q9BS34
GHKVILAACSTFMRD	ZBTB6	46	Q15916
EDEHLVFFCQMGKRG	TSTD1	71	Q8NFU3
DMHCIFVGAESLFLK	N4BP1	86	O75113